- Health
-
Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Metabolic Health, Diabetes & Obesity
Vaccines
Biotech- and Nanotechnology
Ph.D
Canada
Re-establishing self-tolerance by targeting MHC class II-restricted autoimmunity
Juvenile diabetes is an autoimmune disease resulting from an attack that destroys pancreatic cells that secrete insulin. Javier Clemente Casares is studying a therapeutic approach that could lead to a nanovaccine for the disease.
A nanovaccine for juvenile diabetes
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Javier
CLEMENTE-CASARES
Institution
University of Calgary
Country
Canada
Nationality
Spanish
Related publications
Health
Health Technologies
Medical Treatment & Drug Development
Biotech- and Nanotechnology
Drug Delivery
France
Abolishing frontiers between fundamental science and medicine : building on the potential of biomedical ultrasound
Read more
Mickaël
TANTER
Institut National de la Santé et de la Recherche Médicale
